2nd NCRI AML Academy

Diagnosis and Management of Adult AML: Where are we in 2020?

Organiser: Professor Charles Craddock (Birmingham)
Co-Chairs: Dr Mike Dennis (Manchester) & Dr Steve Knapper (Cardiff)

room IET Austin Court, 80 Cambridge Street, Birmingham B1 2NP

Programme

  • Thursday 8th October - NCRI AML Academy

    Chair: Professor Charles Craddock, Birmingham

  • 16:00

    25 years of UK AML Trials - what have we learned?

    Professor Alan Burnett, POG-LR, University of Glasgow

  • 16:30

    AML 18, AML 19 and LI1

    Professor Nigel Russell, London
    Dr Mike Dennis, Manchester

  • 17:15

    Transplant trials

    Dr Victoria Potter, London

  • 17:35

    MRD - update and cases

    Dr Richard Dillon, London
    Professor Sylvie Freeman, Birmingham

  • 18:10

    Coffee

  • 18:30

    AML 20

    Professor Charles Craddock, Birmingham
    Dr Steve Knapper, Cardiff
    Dr Simon Stanworth, Oxford

  • 19:10

    EVOLVE

    Professor Paresh Vyas, Oxford
    Dr Mike Dennis, Manchester

  • 19:40

    Close of Day One

  • Friday 9th October - NCRI AML Academy

  • Plenary Session

    Chairs: Dr Steve Knapper, Cardiff
    Professor Sylvie Freeman, Birmingham

  • 09:30

    Genomics in the diagnosis and management of AML in 2020

    Professor Brian Huntly, Cambridge

  • 09:55

    Novel therapeutic strategies in relapsed AML

    Professor Paresh Vyas, Oxford
    Dr Victoria Potter, London

  • David Grimwade Memorial Lecture

    Chair: Professor Charles Craddock, Birmingham

  • 10:20

    Advances in the management of APML

    Professor Uwe Platzbecker, Leipzig, Germany (Recorded)

  • 10:50

    Discussion

    Live link for questions

  • 11:00

    Coffee

  • Transplant Roundtable Workshop

    Chair: Dr Victoria Potter, London

  • 11:15

    Presented cases for panel discussion

    Panel:
    Dr Erin Hurst, Newcastle
    Dr Rachel Protheroe, Bristol
    Dr Eleni Tholouli, Manchester
    Dr Wendy Ingram, Cardiff

    Recorded case studies - live in Birmingham for interactive roundtable on stage

  • 12:15

    Lunch

  • Plenary Session

    Chair: Dr Mike Dennis, Manchester

  • 13:00

    Venetoclax as a potential game-changer in the management of older (and younger) adults with AML
    Professor Andrew Wei, Melbourne, Australia (Recorded)

    Discussion

    Emerging drug and antibody targeted therapies in AML
    Professor Naval Daver, MD Anderson, Texas (Recorded)

    Questions and discussion
    Live link to speakers for Q & A

  • 14:25

    Coffee break

  • Debate

    Chair: Dr Steve Knapper, Cardiff

  • 14:45

    DA is still the standard induction therapy for all fit AML patients in the UK

    For:
    Dr Priyanka Mehta, Bristol
    Dr Eleni Tholouli, Manchester

    Against:
    Professor Asim Khwaja, London
    Dr Paul Cahalin, Blackpool

  • 15:45

    Summary

    Professor Charles Craddock, Birmingham

  • 15:45

    Close of main session

  • 15:55

    Nurses Session

    Sarah Watmough and Kirsty Halliwell
    AML Trials Unit

  • 16:45

    Close